FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway

Cisplatin resistance is frequently occurred in ovarian cancer therapy, understanding its regulatory mechanisms is critical for developing novel treatment methods and drugs. Here, we found ovarian cancer patients with low FAM83B levels had shorter survival time, tissues with cisplatin resistance also...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shanyang, Wang, Wei, Wan, Zhiyong, Shen, Hongwei, Zhao, Yunhe, You, Zeshan, Liu, Jun, Zhu, Liwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797002/
https://www.ncbi.nlm.nih.gov/pubmed/33423038
http://dx.doi.org/10.1038/s41389-020-00301-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797002/
https://www.ncbi.nlm.nih.gov/pubmed/33423038
http://dx.doi.org/10.1038/s41389-020-00301-y

Ejemplares similares